{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T14:10:02Z","timestamp":1756131002135,"version":"3.44.0"},"reference-count":56,"publisher":"Informa UK Limited","issue":"3","funder":[{"name":"United States Department of Health and Human Services, National Institutes of Health"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["2 UM1 AI068614-15"],"award-info":[{"award-number":["2 UM1 AI068614-15"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["AJOB Empirical Bioethics"],"published-print":{"date-parts":[[2025,7,3]]},"DOI":"10.1080\/23294515.2025.2497753","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T09:55:49Z","timestamp":1745834149000},"page":"185-199","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["The Representative Studies Rubric: A Tool for Diversity in Clinical Trials"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8447-390X","authenticated-orcid":false,"given":"Brian","family":"Minalga","sequence":"first","affiliation":[{"name":"The Legacy Project, Office of HIV\/AIDS Network Coordination, Fred Hutchinson Cancer Center","place":["Seattle, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rona","family":"Siskind","sequence":"additional","affiliation":[{"name":"Axle Informatics","place":["Bethesda, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Campbell","sequence":"additional","affiliation":[{"name":"The Legacy Project, Office of HIV\/AIDS Network Coordination, Fred Hutchinson Cancer Center","place":["Seattle, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"Adamson","sequence":"additional","affiliation":[{"name":"The Legacy Project, Office of HIV\/AIDS Network Coordination, Fred Hutchinson Cancer Center","place":["Seattle, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Allegra","family":"Cermak","sequence":"additional","affiliation":[{"name":"Advancing Clinical Therapeutics Globally","place":["Bethesda, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annet","family":"Davis","sequence":"additional","affiliation":[{"name":"School of Nursing, University of Pennsylvania","place":["Philadelphia, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddie D.","family":"Givens","sequence":"additional","affiliation":[{"name":"The Legacy Project, Office of HIV\/AIDS Network Coordination, Fred Hutchinson Cancer Center","place":["Seattle, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Dyer","sequence":"additional","affiliation":[{"name":"FHI 360","place":["Durham, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"McCarthy","sequence":"additional","affiliation":[{"name":"FHI 360","place":["Durham, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole A.","family":"Monta\u00f1ez","sequence":"additional","affiliation":[{"name":"FHI 360","place":["Durham, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhonda","family":"White","sequence":"additional","affiliation":[{"name":"FHI 360","place":["Durham, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the RSR Working Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258858"},{"key":"e_1_3_5_3_1","unstructured":"ATAC (AIDS Treatment Activists Coalition). 2021. Missing data missing diversity: Participant demographics in industry-sponsored HIV studies 2010-2020. Accessed June 03 2024. https:\/\/aidstreatmentactivists.org\/wp-content\/uploads\/2021\/03\/ATAC-Diversity-Final-Report.pdf"},{"key":"e_1_3_5_4_1","unstructured":"AVAC & HANC (The Office of HIV\/AIDS Network Coordination). 2023. No data no more scorecard tool for trans and gender-diverse inclusivity in HIV clinical trials. Accessed May 28 2024. https:\/\/www.hanc.info\/content\/dam\/hanc\/resources\/No-Data-No-More-Scorecard.pdf"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adq214"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02744-3"},{"key":"e_1_3_5_7_1","unstructured":"Colville D. 2017. Medicine\u2019s gender revolution: How women stopped being treated as \u2018small men.\u2019 Accessed May 28 2024. https:\/\/theconversation.com\/medicines-gender-revolution-how-women-stopped-being-treated-as-small-men-77171."},{"key":"e_1_3_5_8_1","unstructured":"Emanuel G. 2024. DRC is seeing its worst mpox outbreak \u2013 but has no vaccines or treatments yet. Why? Goats and Soda. Accessed June 03 2024. https:\/\/www.npr.org\/sections\/goatsandsoda\/2024\/04\/26\/1247460477\/drc-is-seeing-its-worst-mpox-outbreak-but-has-no-vaccines-or-treatments-yet-why."},{"key":"e_1_3_5_9_1","unstructured":"FDA (United States Food and Drug Administration). 2020a. 21st century cures act. Accessed January 3 2025. https:\/\/www.fda.gov\/regulatory-information\/selected-amendments-fdc-act\/21st-century-cures-act."},{"key":"e_1_3_5_10_1","unstructured":"FDA (United States Food and Drug Administration). 2020b. Enhancing the diversity of clinical trial populations \u2013 eligibility criteria enrollment practices and trials designs: Guidance for industry. Accessed September 18 2022. https:\/\/www.fda.gov\/media\/127712\/download."},{"key":"e_1_3_5_11_1","unstructured":"FDA (United States Food and Drug Administration). 2024. Diversity action plans to improve enrollment from underrepresented populations in clinical studies: Draft guidance for industry. Accessed July 9 2024. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/diversity-action-plans-improve-enrollment-participants-underrepresented-populations-clinical-studies."},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37640"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/11287462.2020.1773061"},{"key":"e_1_3_5_14_1","unstructured":"Frick M. 2024. TB Representative Studies Rubric (TB RSR) to assessing and advocate for equity and representation in research. Presented at The Union World Conference on Lung Health Bali Indonesia November 13. https:\/\/unionconf2024.abstractserver.com\/programme\/#\/details\/presentations\/1790."},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2022.2587"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15242"},{"key":"e_1_3_5_17_1","unstructured":"Haupt S. C. Carcel and R. Norton. 2024. Neglecting sex and gender in research is a public-health risk. Nature. Accessed May 24 2024. https:\/\/www.nature.com\/articles\/d41586-024-01372-2."},{"key":"e_1_3_5_18_1","unstructured":"International covenant on economic social and cultural rights. 1966. Accessed May 28 2024. https:\/\/www.ohchr.org\/en\/instruments-mechanisms\/instruments\/international-covenant-economic-social-and-cultural-rights."},{"key":"e_1_3_5_19_1","unstructured":"Joseph A. 2023. Vaccine experts urge more inclusivity in clinical trials. Stat. Accessed June 03 2024. https:\/\/www.statnews.com\/2023\/09\/05\/vaccine-experts-urge-more-inclusivity-in-clinical-trials\/."},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/nur.21753"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe1206"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1353\/hpu.2006.0126"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106740"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2404784"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2311948"},{"key":"e_1_3_5_26_1","unstructured":"Marrazzo J. 2024. Our words have power\u2014NIAID embraces respectful inclusive and person-first language. NIAID Now Blog. Accessed July 2 2024. https:\/\/www.niaid.nih.gov\/news-events\/our-words-have-power"},{"key":"e_1_3_5_27_1","unstructured":"Maxwell A. 2024. Plans and enrollment often fell short for underrepresented groups in a sample of NIH-funded clinical trials. Accessed May 24 2024. https:\/\/oig.hhs.gov\/documents\/evaluation\/9900\/OEI-01-21-00320.pdf"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)028096-3"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.17226\/26479"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.17226\/26424"},{"key":"e_1_3_5_31_1","unstructured":"National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. 1979. The Belmont report: Ethical principles and guidelines for the protection of human subjects of research. Accessed June 03 2024. https:\/\/www.hhs.gov\/ohrp\/regulations-and-policy\/belmont-report\/index.html."},{"key":"e_1_3_5_32_1","unstructured":"National Institute of Allergy and Infectious Diseases. 2024. NIAID HIV language guide. Accessed May 30 2024. https:\/\/www.niaid.nih.gov\/research\/hiv-language-guide"},{"key":"e_1_3_5_33_1","unstructured":"NIMHD (National Institute on Minority Health and Health Disparities). 2024. Diversity and inclusion in clinical trials. Accessed May 24 2024. https:\/\/www.nimhd.nih.gov\/resources\/understanding-health-disparities\/diversity-and-inclusion-in-clinical-trials.html."},{"key":"e_1_3_5_34_1","unstructured":"National Institutes of Health. 1998. NIH policy and guidelines on the inclusion of children as participants in research involving human subjects. Accessed July 3 2024. https:\/\/grants.nih.gov\/grants\/guide\/notice-files\/not98-024.html."},{"key":"e_1_3_5_35_1","unstructured":"National Institutes of Health. 2001. NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research. Accessed May 24 2024. https:\/\/grants.nih.gov\/policy\/inclusion\/women-and-minorities\/guidelines.htm."},{"key":"e_1_3_5_36_1","unstructured":"NIAID Division of AIDS Cross-Network Transgender and Gender-Diverse Working Group. 2023. Recommendations for collecting data on gender identity sex assigned at birth intersex status and sexual orientation. Accessed May 22 2024. https:\/\/www.hanc.info\/content\/dam\/hanc\/resources\/Data-Collection.pdf."},{"key":"e_1_3_5_37_1","unstructured":"NIH ORWH (NIH Office of Research on Women\u2019s Health). 2024. Clinical research and trials. Accessed May 24 2024. https:\/\/orwh.od.nih.gov\/womens-health-equity-inclusion\/clinical-research-and-trials."},{"key":"e_1_3_5_38_1","unstructured":"NIH ORWH (NIH Office of Research on Women\u2019s Health). 2024. NIH guidelines: inclusion of pregnant women in clinical research. Accessed May 28 2024. https:\/\/orwh.od.nih.gov\/toolkit\/nih-policies-inclusion\/guidelines."},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2055-6640(20)30019-4"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/538161a"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2822"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/17407745221149118"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142029"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.14151"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2215609"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1728-4465.2014.00393.x"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2022.07.037"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00316-8"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00729-6"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31530-0"},{"key":"e_1_3_5_51_1","unstructured":"TAG (Treatment Action Group). 2018. Demographics of participation in HIV cure-related clinical research. Accessed June 04 2024. https:\/\/www.treatmentactiongroup.org\/cure\/resource-on-the-demographics-of-participation-in-hiv-cure-related-clinical-research\/."},{"key":"e_1_3_5_52_1","unstructured":"Trinity Life Sciences. 2022. Diversity in clinical trials participation: A life sciences perspective. Accessed June 03 2024. https:\/\/trinitylifesciences.com\/wp-content\/uploads\/2022\/05\/Trinity-Whitepaper-Diversity-in-Clinical-Trials-Participation.pdf."},{"key":"e_1_3_5_53_1","unstructured":"UNAIDS. 2023. The Denver principles: 40 years on. Accessed January 8 2025. https:\/\/www.unaids.org\/en\/resources\/presscentre\/featurestories\/2023\/june\/20230626_denver-principles-40-years-on."},{"key":"e_1_3_5_54_1","unstructured":"Uscher J. 2023. Special report: Increasing racial diversity in breast cancer clinical trials. Accessed June 03 2024. https:\/\/www.breastcancer.org\/treatment\/clinical-trials\/diversity-in-trials#why."},{"key":"e_1_3_5_55_1","unstructured":"Wilder T. 2023. How to avoid repeating the same mistakes in HIV research: An interview with LaRon E. Nelson. TheBodyPro. Accessed June 03 2024. https:\/\/www.thebodypro.com\/article\/how-to-avoid-repeating-same-mistakes-hiv-research-laron-e-nelson."},{"key":"e_1_3_5_56_1","unstructured":"World Bank. 2021. Fertility rate: Rankings in Africa. Accessed July 5 2024. https:\/\/datacommons.org\/place\/country\/NER?category=Demographics#Fertility-rate"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"}],"container-title":["AJOB Empirical Bioethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/23294515.2025.2497753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T13:57:59Z","timestamp":1756130279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/23294515.2025.2497753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7,3]]}},"alternative-id":["10.1080\/23294515.2025.2497753"],"URL":"https:\/\/doi.org\/10.1080\/23294515.2025.2497753","relation":{},"ISSN":["2329-4515","2329-4523"],"issn-type":[{"type":"print","value":"2329-4515"},{"type":"electronic","value":"2329-4523"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=uabr21","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=uabr21","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-04-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}